SHIMADZU AND PHENOMENOME DISCOVERIES ENHANCE GLOBAL PROFILING SOFTWARE FOR BIOMARKER DISCOVERY

New Phenomenome Profiler™ Plus software maximizes information- rich IT-TOF MS data to aid biomarker discovery and global profiling studies

At ASMS 2007, Shimadzu Corporation and Phenomenome Discoveries Inc. (PDI), a leading provider of software tools for metabolomics analysis, launched enhancements to Phenomenome Profiler™ metabolomics software to support high mass-accuracy MSn data. This brings together the unique mass spectrometry of the LCMS-IT-TOF quadrupole ion trap-time of flight instrument from Shimadzu with an integrated approach to global profiling with Phenomenome Profiler™ software.

The new software has been developed under an existing collaboration between the two life science companies and strengthens the integration of information-rich mass spectrometry data with the data mining tools of Phenomenome Profiler™ software.

“Phenomenome Profiler™ software has been further developed to work seamlessly with the LCMS-IT-TOF technology, supporting not only high mass accuracy MSn data streams, but also fast polarity switching. The new Phenomenome Profiler™ Plus software tools will help researchers view and interpret complex data sets quickly and with greater efficiency,” said Kozo Shimazu, Corporate Officer, Deputy General Manager for Mass Spectrometry and Life Science at Shimadzu Corporation.

“Our two companies have been working together for the past 24 months to help develop an integrated solution for researchers in biomarker discovery and global profiling studies. We are both excited about the success of this collaboration and the possibility of further expansion into identifying key markers for disease,” stated John Hyshka, COO of Phenomenome Discoveries.

-ends-

About Shimadzu Biotech

Shimadzu Biotech is a strategic global brand of Shimadzu Corporation. Shimadzu Biotech is focused on providing integrated solutions for life science and drug development to accelerate the progress of biotechnology in research and development. Shimadzu Biotech represents a new way of thinking in the health and life science sectors by combining a core competence in instrument design and manufacture together with strategic partnerships to advance the development of knowledge in biotechnology. Product offerings include mass spectrometry integrated with enabling technology for high throughput analysis (MALDI, LC/MS, automated systems for analyzing gels with mass spectrometry) and specific solutions for DNA analysis (ranging from UV spectroscopy tochip-based electrophoresis) among a range of other offerings.

About Phenomenome Discoveries Inc.

Phenomenome Discoveries Inc. is a privately owned company located in Saskatoon, Canada. Utilizing its patented metabolomics platform, PDI conducts human health research and biomarker discovery. Phenomenome Informatics, a division of PDI, in November 2004 launched Phenomenome Profiler™, the first instrument-independent informatics platform designed for the visualization and interpretation of mass spectrometry small molecule data. PDI has in-house and collaborative research programs, and offers contract research solutions. www.phenomenome.com

For more information, please contact:

Phenomenome Discoveries Contacts

Shimadzu Biotech